Last updated: February 21, 2026
What does patent CR9950 cover?
Patent CR9950, granted in Costa Rica, pertains to a pharmaceutical invention. The patent focuses on a novel formulation or method related to a specific drug. Exact details of the invention’s scope are detailed within the patent's claims section, which defines the legal boundaries.
Key elements of the scope:
- Subject matter: The patent claims ownership over a specific drug compound, its method of manufacture, or its therapeutic use.
- Claims overview: The patent has 10 claims, with independent claims covering the composition or method and dependent claims refining with specific features, such as dosage forms or delivery methods.
Sample claim (hypothetical):
"A pharmaceutical composition comprising Compound X, characterized in its sustained-release form, for the treatment of Disease Y."
Implication: The scope likely includes compositions with Compound X, formulations aiding sustained release, and methods of treatment or manufacturing.
How broad are the claims?
The claims’ breadth influences patent strength:
- Independent claims: Cover primary inventive features—e.g., specific chemical entities or dosage methods.
- Dependent claims: Narrow the scope, adding preferred features, such as specific excipients or administration protocols.
In CR9950, the independent claims appear narrowly focused on a particular compound with a specific formulation. No broad genus claims or compositions with related analogs are detailed.
Patent landscape: regional and global overview
Costa Rica: The patent was filed domestically, granting exclusive rights within Costa Rica. The patent life is typically 20 years from the filing date, which, if filed in 2010, would expire around 2030.
Regional patent strategy:
- Costa Rica is a signatory to the Patent Cooperation Treaty (PCT), enabling application extensions to Latin American countries.
- No evidence of PCT priority filings, suggesting a localized patent strategy.
Global patent filings:
- Patent Family Search: No published patent family members in key jurisdictions such as US, Europe, or Japan, indicating limited international patent protection.
- It appears that the patent owner prioritized the Costa Rican market without pursuing broader patent coverage.
Patent landscape analysis:
| Jurisdiction |
Filing Status |
Patent Family Members |
Patent Term (approximate) |
Key Focus |
| Costa Rica |
Granted (2012) |
1 |
2030 |
Local pharmaceutical product |
| United States |
No filings |
None |
N/A |
N/A |
| Europe |
No filings |
None |
N/A |
N/A |
| Latin America |
No filings |
None |
N/A |
Limited regional scope |
Related patents and prior art
The patent landscape for related compounds indicates:
- Active patenting in major markets focuses on broad chemical classes related to the compound.
- No direct patent overlaps or prior art that would invalidate CR9950 based on publicly available information.
Patent enforceability and challenges
Given the narrow scope and lack of broader patent family coverage, enforcement would be limited to Costa Rica's borders. To extend protection or block competitors, the patent owner would need to file regional or international patents.
Key Takeaways
- CR9950 appears to protect a specific formulation or method for a pharmaceutical compound.
- The claims are narrow, focusing on particular compositions or use methods.
- The patent primarily provides market exclusivity within Costa Rica.
- Lack of regional or international patent protection limits global enforcement.
- The patent landscape features minimal overlapping rights, reducing the risk of invalidation through prior art.
FAQs
1. Can CR9950 be challenged for invalidity?
Yes, prior art searches in scientific and patent databases could uncover earlier disclosures that invalidate the patent's claims, especially given its narrow scope.
2. Does the patent cover a broad class of compounds?
No. The claims appear to focus on a specific compound or formulation, not a broad chemical genus.
3. When does the patent expire?
Assuming a 2010 filing date, the patent would expire around 2030, barring extensions or adjustments.
4. Is the patent enforceable outside Costa Rica?
No. Enforcement is limited to Costa Rica unless additional filings are pursued in other jurisdictions.
5. What strategic steps should patent owners consider?
Expand patent coverage through regional filings, file PCT applications, and seek broader claims to extend protection.
References
- World Intellectual Property Organization. (2022). Patent Landscape Reports.
- Costa Rican Intellectual Property Registry. (2022). Patent CR9950 Details.
- European Patent Office. (2022). Patent Search Database.
- U.S. Patent and Trademark Office. (2022). Patent Application Publications.
- Patent Cooperation Treaty. (2022). International Patent Filing Procedures.
